Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Boston BioSolutions is a specialty pharmaceutical and medical device company focused on the development and commercialization of advanced products for ophthalmic surgery. The company specializes in high-purity surgical dyes and tamponade agents that enhance visualization and surgical precision during complex vitreoretinal and cataract procedures. Their core product line includes BBS-Blue (Brilliant Blue G), BBS-Trypan (Trypan Blue), and a range of perfluorocarbon liquids and silicone oils. By prioritizing product purity and safety, Boston BioSolutions aims to reduce the risk of retinal toxicity and improve patient outcomes in ophthalmic care. The company is headquartered in Woburn, Massachusetts, and serves a global market of ophthalmic surgeons and healthcare facilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Boston BioSolutions.